Jonathan S. Cebon
Experienced in Neuroendocrine Tumor

Jonathan S. Cebon

Melbourne Austin Branch, 
Melbourne, VIC, AU 
Experienced in Neuroendocrine Tumor
Melbourne Austin Branch, 
Melbourne, VIC, AU 
OverviewLocationsClinical Research

Overview

Jonathan Cebon practices in Melbourne, Australia. Mr. Cebon is rated as an Experienced expert by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Melanoma, Metastatic Brain Tumor, Testicular Cancer, Neuroendocrine Tumor, and Liver Embolization.

His clinical research consists of co-authoring 123 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles and participated in 3 clinical trials in the study of Neuroendocrine Tumor.

Gender
Male

Locations

Melbourne Austin Branch, Melbourne, VIC, Australia
Other Locations
145 Studley Road, Melbourne, VIC 3084, Australia
Studley Road, Heidelberg, VIC 3084, Australia
Melbourne Austin Branch, Heidelberg, VIC, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase II Clinical Trial Evaluating Ipilimumab and Nivolumab in Combination for the Treatment of Rare Gastrointestinal, Neuro-Endocrine and Gynaecological Cancers
A Phase II Clinical Trial Evaluating Ipilimumab and Nivolumab in Combination for the Treatment of Rare Gastrointestinal, Neuro-Endocrine and Gynaecological Cancers
Enrollment Status: Completed
Publish Date: July 24, 2024
Intervention Type: Drug
Study Drugs: Ipilimumab, Nivolumab
Study Phase: Phase 2
A Phase II Study of the Clinical and Immunological Effects of NY-ESO-1 ISCOM® Vaccine in Patients With Measurable Stage III and IV Malignant Melanoma
A Phase II Study of the Clinical and Immunological Effects of NY-ESO-1 ISCOM® Vaccine in Patients With Measurable Stage III and IV Malignant Melanoma
Enrollment Status: Completed
Publish Date: October 25, 2022
Intervention Type: Biological, Drug
Study Phase: Phase 2
A Phase I Study of Intralesional Bacillus Calmette-Guerin (BCG) and Followed by Ipilimumab Therapy in Patients With Advanced Metastatic Melanoma
A Phase I Study of Intralesional Bacillus Calmette-Guerin (BCG) and Followed by Ipilimumab Therapy in Patients With Advanced Metastatic Melanoma
Enrollment Status: Terminated
Publish Date: October 12, 2022
Intervention Type: Drug, Biological
Study Phase: Phase 1
A Phase I/II Open-label Trial of Intravenous CAVATAK^TM in Combination With Pembrolizumab for the Treatment of Patients With Advanced NSCLC
A Phase I/II Open-label Trial of Intravenous CAVATAK^TM in Combination With Pembrolizumab for the Treatment of Patients With Advanced NSCLC
Enrollment Status: Unknown
Publish Date: July 07, 2021
Intervention Type: Biological, Drug
Study Drugs: Pembrolizumab, CVA21
Study Phase: Phase 1
View 3 Less Clinical Trials

123 Total Publications

Common inherited loss-of-function mutations in the innate sensor NOD2 contribute to exceptional immune response to cancer immunotherapy.
Common inherited loss-of-function mutations in the innate sensor NOD2 contribute to exceptional immune response to cancer immunotherapy.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: July 07, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Cebon's expertise for a condition
ConditionClose
    View All 19 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile